Aceragen's announcement to delist from the Nasdaq is a significant event that directly impacts its stock price. Delisting often leads to a decrease in share prices as it can be seen as a negative signal about the company's financial health or future prospects. This is reflected in the drop in Aceragen's share prices following the announcement.